Pasithea Therapeutics shares are trading higher after Lucy Scientific Discovery proposed to acquire the company for $0.60 per share in cash and $0.25 per share in Lucy stock.
Portfolio Pulse from Benzinga Newsdesk
Pasithea Therapeutics shares are trading higher after Lucy Scientific Discovery proposed to acquire the company for $0.60 per share in cash and $0.25 per share in Lucy stock.
June 05, 2023 | 3:24 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Pasithea Therapeutics' stock price is trading higher following Lucy Scientific Discovery's acquisition proposal at $0.60 cash and $0.25 stock per share.
The acquisition proposal by Lucy Scientific Discovery directly impacts Pasithea Therapeutics' stock price, as it offers a premium to the current trading price. This news is highly relevant and important for investors in KTTA, as it indicates a potential change in ownership and valuation of the company. The confidence in this analysis is high, as the acquisition proposal is a significant event for the company.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100